HomeCompareVIRI vs GBDC

VIRI vs GBDC: Dividend Comparison 2026

VIRI yields 1290.32% · GBDC yields 11.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VIRI wins by $2.3960825995340865e+24M in total portfolio value
10 years
VIRI
VIRI
● Live price
1290.32%
Share price
$0.16
Annual div
$2.00
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.3960825995340865e+24M
Annual income
$2,395,725,921,261,555,500,000,000,000,000.00
Full VIRI calculator →
GBDC
GBDC
● Live price
11.86%
Share price
$12.65
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.85M
Annual income
$16,450,733.83
Full GBDC calculator →

Portfolio growth — VIRI vs GBDC

📍 VIRI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVIRIGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VIRI + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VIRI pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VIRI
Annual income on $10K today (after 15% tax)
$109,677.42/yr
After 10yr DRIP, annual income (after tax)
$2,036,367,033,072,322,200,000,000,000,000.00/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.91/yr
After 10yr DRIP, annual income (after tax)
$13,983,123.76/yr
At 15% tax rate, VIRI beats the other by $2,036,367,033,072,322,200,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VIRI + GBDC for your $10,000?

VIRI: 50%GBDC: 50%
100% GBDC50/50100% VIRI
Portfolio after 10yr
$1.1980412997670432e+24M
Annual income
$1,197,862,960,630,777,700,000,000,000,000.00/yr
Blended yield
99.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

VIRI
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
-882.0
Piotroski
1/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.7% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VIRI buys
0
GBDC buys
0
No recent congressional trades found for VIRI or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVIRIGBDC
Forward yield1290.32%11.86%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%51.1%
Portfolio after 10y$2.3960825995340865e+24M$20.85M
Annual income after 10y$2,395,725,921,261,555,500,000,000,000,000.00$16,450,733.83
Total dividends collected$2.3960592593715676e+24M$20.43M
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusHoldBuy

Year-by-year: VIRI vs GBDC ($10,000, DRIP)

YearVIRI PortfolioVIRI Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$268,765$258,064.52$12,492$1,791.70+$256.3KVIRI
2$13,251,799$12,964,221.46$16,527$3,160.58+$13.24MVIRI
3$1,208,980,447$1,194,801,021.45$23,588$5,904.90+$1208.96MVIRI
4$205,038,263,945$203,744,654,866.63$37,141$11,901.65+$205038.23MVIRI
5$64,806,832,428,888$64,587,441,486,467.30$66,205$26,463.38+$64806832.36MVIRI
6$38,226,866,599,812,776$38,157,523,289,113,870.00$137,452$66,612.65+$38226866599.68MVIRI
7$42,111,076,145,403,994,000$42,070,173,398,142,190,000.00$342,372$195,298.53+$42111076145403.65MVIRI
8$86,671,038,474,809,380,000,000$86,625,979,623,333,790,000,000.00$1,053,292$686,954.33+$86671038474809392.00MVIRI
9$333,344,179,935,764,700,000,000,000$333,251,441,924,596,600,000,000,000.00$4,111,439$2,984,416.95+$333344179935764676608.00MVIRI
10$2,396,082,599,534,086,500,000,000,000,000$2,395,725,921,261,555,500,000,000,000,000.00$20,849,974$16,450,733.83+$2.3960825995340865e+24MVIRI

VIRI vs GBDC: Complete Analysis 2026

VIRIStock

Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, LLC and changed its name to Virios Therapeutics, Inc. in December 2020. Virios Therapeutics, Inc. was founded in 2012 and is headquartered in Alpharetta, Georgia.

Full VIRI Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this VIRI vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VIRI vs SCHDVIRI vs JEPIVIRI vs OVIRI vs KOVIRI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.